Physician profile
Kent Gregory Davis
NPI 1972590644
$4,430.51
in general payments reported to CMS, 2019-2025
25 companies · $690 in 2025
The $690 reported for 2025 was more than what 78% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $736 · 2020: $297 · 2021: $383 · 2022: $810 · 2023: $1,014 · 2024: $500 · 2025: $690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,201 · Travel and Lodging: $3.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,200.71 |
| Travel and Lodging | $3.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $965.96 | 2019-2023 | Acclarent Aera, Trudi Nav Cable, Relieva Spinplus |
| Medtronic, INC. | $638.16 | 2022-2025 | Propel, Sinuva, Fusion |
| Stryker Corporation | $422.17 | 2019-2022 | |
| Optinose US, INC. | $384.08 | 2019-2022 | |
| Integra Lifesciences Corporation | $349.74 | 2024-2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Glaxosmithkline, LLC. | $258.73 | 2022-2025 | Nucala |
| Genzyme Corporation | $224.47 | 2022-2025 | |
| Neurent Medical Limited | $215.95 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Intersect Ent, INC. | $153.66 | 2019-2021 | |
| Hologic Sales and Service, LLC | $148.38 | 2024 | Coolseal Generator |
| Inspire Medical Systems, INC. | $136.81 | 2022 | |
| Aerin Medical INC. | $128.42 | 2019 | |
| Medtronic USA, INC. | $118.53 | 2019 | |
| Axogen | $48.08 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $37.54 | 2024 | Dupixent |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $31.32 | 2019 | |
| Boston Scientific Corporation | $28.50 | 2023 | Watchman Flx |
| Galderma Laboratories, L.P. | $24.88 | 2024 | |
| Allergan, INC. | $23.53 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.23 | 2024 | Iovera, Exparel |
| Arbor Pharmaceuticals, INC. | $16.04 | 2019 | |
| Olympus America INC. | $15.88 | 2023 | Olympus |
| Novartis Pharmaceuticals Corporation | $15.66 | 2023 | |
| Baudax Bio INC. | $14.00 | 2020 | |
| 3b Medical, INC. | $8.79 | 2024 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.